TAUCHA MILLER: Open Payments
NPI 1790300366 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 75 payments from 15 companies in 2025. Trend: 2023 $977 · 2024 $817 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $215 |
| Vanda Pharmaceuticals Inc. | 4 | $168 |
| Lundbeck LLC | 5 | $98 |
| Novo Nordisk Inc | 4 | $75 |
| Exact Sciences Corporation | 3 | $61 |
| Alkermes, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Seqirus USA Inc | 1 | $25 |
Products named: CAPLYTA, FANAPT, VRAYLAR, REXULTI, UBRELVY, VIVITROL, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across WV — which companies pay providers there.
